Clinical factors associated with Guillain-Barré syndrome following surgery. Issue 3 (June 2018)

• Record Type: Journal Article
• Authors: Hocker, Sara; Nagarajan, Elanagan; Rubin, Mark; Wijdicks, Eelco F.M.
• Is Part Of: Neurology. Volume 8:Issue 3(2018)
• Publication Date: 2018-06
• Subjects: Nervous system -- Diseases -- Periodicals; Neurology -- Periodicals; Neurology -- United States -- Periodicals; 616.8
• DOI: 10.1212/CPJ.0000000000000451
• Languages: English
• ISSNs: 2163-0402

Abstract

Abstract : Background: We sought to identify clinical associations and potential triggers of Guillain-Barré syndrome (GBS) within 6 weeks of surgery. Methods: We retrospectively reviewed consecutive patients diagnosed with GBS within 6 weeks of a surgery between January 1995 and June 2014 at Mayo Clinic. Postsurgical GBS was defined as symptom onset within 6 weeks of surgery. Patients with postsurgical GBS were compared with patients who did not have a surgery prior to GBS onset to determine differences between groups. Results: A total of 208 patients with GBS, median age 55 years (interquartile range [IQR] 41–68), were included. Nineteen patients (9.1%) developed postsurgical GBS. Median duration from the surgery to onset of first GBS symptom was 15 days (IQR 9–37). The main types of surgeries preceding GBS were gastrointestinal, orthopedic, and cardiac. General anesthesia was used in 18 (95%) and conscious sedation in 1 (5%) patient. Among the 19 patients with postsurgical GBS, 11 (57.9%) had a known diagnosis of malignancy. Autoimmune conditions were present in 5 (26.3%) patients. Postoperative infection was found in 4 (21%) patients. On univariate analysis, the factors that showed an association with postsurgical GBS were age ( p = 0.02), malignancy ( p ⩽ 0.0004), active malignancy ( p = 0.03), preexisting autoimmune disorder ( p = 0.02), and infection ( p = 0.0001). On multivariate analysis, only active malignancy (0.03) remained associated. Conclusions: Surgery antedated GBS in 9.1% of patients. Postsurgical GBS was more common in patients with an active malignancy. A prospective study is needed to determine whether active malignancy represents an independent risk factor for the development of postsurgical GBS.